{"id":147637,"date":"2022-10-06T09:22:19","date_gmt":"2022-10-06T14:22:19","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/10\/research-team-achieves-breakthrough-in-the-production-of-an-acclaimed-cancer-treating-drug"},"modified":"2022-10-06T09:22:19","modified_gmt":"2022-10-06T14:22:19","slug":"research-team-achieves-breakthrough-in-the-production-of-an-acclaimed-cancer-treating-drug","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/10\/research-team-achieves-breakthrough-in-the-production-of-an-acclaimed-cancer-treating-drug","title":{"rendered":"Research team achieves breakthrough in the production of an acclaimed cancer-treating drug"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/research-team-achieves-breakthrough-in-the-production-of-an-acclaimed-cancer-treating-drug.jpg\"><\/a><\/p>\n<p>Stanford University researchers have discovered a rapid and sustainable way to synthetically produce a promising cancer-fighting compound right in the lab. The compound\u2019s availability has been limited because its only currently known natural source is a single plant species that grows solely in a small rainforest region of Northeastern Australia.<\/p>\n<p>The compound, designated EBC-46 and technically called tigilanol tiglate, works by promoting a localized <a href=\"https:\/\/phys.org\/tags\/immune+response\/\" rel=\"tag\" class=\"\">immune response<\/a> against tumors. The response breaks apart the <a href=\"https:\/\/phys.org\/tags\/tumor\/\" rel=\"tag\" class=\"\">tumor<\/a>\u2019s blood vessels and ultimately kills its cancerous cells. EBC-46 recently entered into <a href=\"https:\/\/phys.org\/tags\/human+clinical+trials\/\" rel=\"tag\" class=\"\">human clinical trials<\/a> following its extremely high success rate in treating a kind of cancer in dogs.<\/p>\n<p>Given its complex structure, however, EBC-46 had appeared synthetically inaccessible, meaning no plausible path seemed to exist for producing it practically in a laboratory. However, thanks to a clever process, the Stanford researchers demonstrated for the first time how to chemically transform an abundant, plant-based starting material into EBC-46.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stanford University researchers have discovered a rapid and sustainable way to synthetically produce a promising cancer-fighting compound right in the lab. The compound\u2019s availability has been limited because its only currently known natural source is a single plant species that grows solely in a small rainforest region of Northeastern Australia. The compound, designated EBC-46 and [\u2026]<\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19],"tags":[],"class_list":["post-147637","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/147637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=147637"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/147637\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=147637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=147637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=147637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}